ImmunityBio, Inc. (IBRX) is listed on NASDAQ in Biotech Stocks. It is $8.05, -4.17%, with a $8.5B market cap. RSI is 54.2, neutral. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 54.2 Neutral
Market Cap $8.5B
Volume 6.0M
Fundamentals — 10-Q Q2 2026
Revenue $95.4M
Net Income $-863.2M
EPS $-0.83
Gross Margin 99.4%
Operating Margin -137.8%
Net Margin -904.3%
P/E Ratio -9.7x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Cohen Cheryl | Director | Sell | 131,210 | $9.50 | $1.2M | 2026 Jul 2 |
| Selecky Christobel | Director | Sell | 159,478 | $9.02 | $1.4M | 2026 Jul 1 |
| Selecky Christobel | Director | Sell | 96,722 | $9.01 | $871,216 | 2026 Jun 30 |
| Simon Barry J. | Director | Sell | 25,000 | $7.88 | $196,908 | 2026 Jun 24 |
| Simon Barry J. | Director | Sell | 23,033 | $7.18 | $165,306 | 2026 Jun 4 |
| Simon Barry J. | Director | Sell | 75,000 | $12.01 | $900,788 | 2026 Feb 24 |
| Selecky Christobel | Director | Sell | 25,000 | $10.00 | $250,000 | 2026 Feb 23 |
| Simon Barry J. | Director | Sell | 175,000 | $10.19 | $1.8M | 2026 Feb 23 |
| Blaszyk Michael D | Director | Buy | 71,915 | $2.75 | $198,023 | 2023 Jun 5 |
| Brennan John Owen | Director | Buy | 25,000 | $2.83 | $70,700 | 2023 Jun 2 |
| Clark Wesley | Director | Buy | 7,000 | $2.91 | $20,370 | 2023 Jun 1 |
| Adcock Richard | CEO & President | Buy | 1,930 | $8.81 | $17,005 | 2021 Oct 8 |
| Cohen Cheryl | Director | Sell | 24,777 | $10.07 | $249,546 | 2021 Aug 23 |
| Cohen Cheryl | Director | Sell | 45,531 | $10.12 | $460,582 | 2021 Aug 18 |
| Simon Barry J. | Director | Sell | 125,000 | $16.14 | $2.0M | 2021 May 25 |
Other Biotech Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $137.93 | 63.6 | $55.1B |
| | $432.33 | 66.2 | $233.7B |
| | $145.64 | 60.3 | $180.6B |
| | $54.45 | 50.2 | $13.5B |
| | $176.24 | 62.2 | $9.9B |
| | $118.23 | 51.7 | $9.8B |
| | $218.46 | 60.5 | $32.3B |
Take IBRX further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put IBRX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when ImmunityBio, Inc. next reports.
Set alerts on IBRX
Get notified when ImmunityBio, Inc. hits your price targets or technical conditions are met.
Get Started Free